Quick Summary GLP-1 drugs like Ozempic work by mimicking a gut hormone that reduces appetite, slows digestion, and lowers blood sugar
The BELIEVE trial was a randomized, double-blind, placebo-controlled Phase 2 study evaluating the effects of semaglutide, bimagrumab, and their combination over 48 weeks, with a 24-week open-label extension
Zal T, Zielinski R, Grela K, Cardenas-Zuniga R, Skora S, Fokt I, Zal MA, Andreeff M , Gil L, Shephard R, Priebe W
Because BPC-157 is not FDA approved for general medical use and human safety data remains limited, patients should not self-dose, order research peptides online, or use BPC-157 without medical supervision
Explore Norton Schools Complete Decongestive Therapy certification programs, continuing education courses, and therapist resources to stay at the forefront of evidence-based lymphedema care.
Dietrich B., Axel W., editors